logo

For the Inventor, By the Inventor

Wuppertal, Germany

Rudiger Sitt

USPTO Granted Patents = 14

Average Co-Inventor Count = 3.8

ph-index = 7

Forward Citations = 228(Granted Patents)


Company Filing History:

goldMedal14 out of 12,160 
 
Bayer Aktiengesellschaft
 patents

Years Active: 1981-1986

Loading Chart...
14 patents (USPTO):Explore Patents
1. 4574124 - Lipid absorption-inhibiting agents and their use (1986-03-04),
2. 4510156 - Bisindolyl alkylene ureas lipid absorption-inhibiting agents and their (1985-04-09),
3. 4466964 - Lipid absorption-inhibiting 1,4-benzothiazines (1984-08-21),
4. 4460607 - Lipid absorption-inhibiting agents and their use (1984-07-17),
5. 4442100 - Substituted 2-amino-3,4-dihydropyridine derivatives, their production (1984-04-10),
6. 4407809 - N-phenoxy(or thio)hydrocarbon 3,4,5-trihydroxypiperidine derivatives, (1983-10-04),
7. 4405644 - Medicaments for the treatment of disorders of lipometabolism and their (1983-09-20),
8. 4348402 - 2-Hydroxyalkyl-3,4,5-trihydroxy-piperidine compounds, their production (1982-09-07),
9. 4330677 - Polyether compounds, their production and their medicinal use (1982-05-18),
10. 4328233 - .alpha.-Glucosidase inhibiting (1982-05-04),
11. 4312872 - 1-Alka-2,4-dienyl-2-hydroxymethyl-3,4,5-trihydroxypiperidines as (1982-01-26),
12. 4293551 - N-Amino-3,4,5-trihydroxypiperidines, their production and their (1981-10-06),
13. 4278683 - Saccharase inhibiting 3,4,5-trihydroxypiperidine derivatives (1981-07-14),
14. 4261988 - Chromanone derivatives (1981-04-14),

Title: The Innovations of Rudiger Sitt: A Pioneer in Lipid Absorption Inhibition

Introduction

Rudiger Sitt, an accomplished inventor based in Wuppertal, Germany, has made significant contributions to the field of medicinal chemistry through his innovative research. With an impressive portfolio of 14 patents, Sitt focuses on the development of lipid absorption-inhibiting agents, which play a vital role in addressing lipid-related health issues.

Latest Patents

Among his notable inventions, Sitt's recent patents include formulations for lipid absorption-inhibiting agents, particularly alkylurea derivatives of specific formulas. These compounds are recognized for their utility as hypolipidemic agents, helping to reduce lipid absorption in the body. His patents detail not only the compositions of these alkylurea derivatives but also methods for their manufacture and use in medicaments.

Career Highlights

Rudiger Sitt works at Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company known for its commitment to innovation. Through his career at Bayer, Sitt has dedicated himself to developing effective pharmacological solutions that can transform the treatment landscape for patients dealing with lipid metabolism disorders.

Collaborations

Throughout his career, Sitt has collaborated with esteemed colleagues such as Hans-Joachim Kabbe and Lutz Muller. These partnerships have facilitated a robust exchange of ideas and have significantly contributed to the advancement of research in lipid absorption inhibition.

Conclusion

Rudiger Sitt's contributions to the field of medicinal chemistry through his innovative patents underline his status as a significant inventor. His work at Bayer Aktiengesellschaft continues to push the boundaries of science in addressing critical health challenges related to lipid absorption. The impact of his inventions promotes better health outcomes and showcases the importance of research and innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…